Immunethep raises additional financing to strengthen strategic industry partnerships and to prepare for clinical trials

18 October 2018


Immunethep, a biotech company that develops anti-bacterial immunotherapies for life-threatening infections, has raised additional funding from its lead investor Portugal Ventures of 0.5+ M€ to further develop strategic industry partnerships and prepare for clinical trials.

Download the Press Release below: